You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

TIROFIBAN HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Tirofiban Hydrochloride, and when can generic versions of Tirofiban Hydrochloride launch?

Tirofiban Hydrochloride is a drug marketed by Eugia Pharma, Gland Pharma Ltd, and Nexus. and is included in three NDAs.

The generic ingredient in TIROFIBAN HYDROCHLORIDE is tirofiban hydrochloride. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tirofiban hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tirofiban Hydrochloride

A generic version of TIROFIBAN HYDROCHLORIDE was approved as tirofiban hydrochloride by GLAND PHARMA LTD on April 8th, 2021.

  Try a Trial

Drug patent expirations by year for TIROFIBAN HYDROCHLORIDE
Recent Clinical Trials for TIROFIBAN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lu HuaPhase 4
Second Affiliated Hospital of Guangxi Medical UniversityPhase 4
CSPC Pharmaceutical Group LimitedPhase 4

See all TIROFIBAN HYDROCHLORIDE clinical trials

Pharmacology for TIROFIBAN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for TIROFIBAN HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AGGRASTAT Injection tirofiban hydrochloride 5 mg/100 mL 020913 1 2019-08-29
AGGRASTAT Injection tirofiban hydrochloride 12.5 mg/250 mL 020913 1 2018-10-03

US Patents and Regulatory Information for TIROFIBAN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma TIROFIBAN HYDROCHLORIDE tirofiban hydrochloride SOLUTION;INTRAVENOUS 216379-001 May 1, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Nexus TIROFIBAN HYDROCHLORIDE tirofiban hydrochloride SOLUTION;INTRAVENOUS 213947-001 Feb 7, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Eugia Pharma TIROFIBAN HYDROCHLORIDE tirofiban hydrochloride SOLUTION;INTRAVENOUS 216379-002 May 1, 2023 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Gland Pharma Ltd TIROFIBAN HYDROCHLORIDE tirofiban hydrochloride SOLUTION;INTRAVENOUS 206888-001 Apr 8, 2021 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.